OMEGA PHARMA NV 02/05/2011 AGM
1Approving the annual report of the board of directors and the auditor's report on the annual accounts for the financial year 2010For
2Communication of the consolidated annual accounts and the consolidated reportsFor
3Approval of the annual accounts closed on December 31st 2010For
4Approve the dividendFor
5Discharge to the members of the board of directors and the auditorOppose
6Remuneration of non-executive directorsFor
7Re-elect Marc CouckeFor
8Re-elect Couckinvest NV, with Marc Coucke as permanent representativeOppose
9Re-elect Sam Sabbe BVBA, with Sam Sabbe as permanent representativeOppose
10Appoint the auditorsFor
11Allow the board to determine the auditors remunerationFor
12Deviation from article 520 ter, section 1 of the Belgian Company CodeFor
13Deviation from article 520 ter, section 2 of the Belgian Company CodeFor
14In accordance with article 556 of the Belgian Company Code, approval of the clauses of change of control as stipulated in (i) the credit agreement entered into with KBC Bank NV on August 24th 2010 and (ii) the revolving credit facility agreement entered into with Fortis Bank NV on 23rd August 2010Abstain
15MiscellaneousOppose